» Articles » PMID: 21470459

Should Remaining Stockpiles of Smallpox Virus (variola) Be Destroyed?

Overview
Date 2011 Apr 8
PMID 21470459
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

In 2011, the World Health Organization will recommend the fate of existing smallpox stockpiles, but circumstances have changed since the complete destruction of these cultures was first proposed. Recent studies suggest that variola and its experimental surrogate, vaccinia, have a remarkable ability to modify the human immune response through complex mechanisms that scientists are only just beginning to unravel. Further study that might require intact virus is essential. Moreover, modern science now has the capability to recreate smallpox or a smallpox-like organism in the laboratory in addition to the risk of nature re-creating it as it did once before. These factors strongly suggest that relegating smallpox to the autoclave of extinction would be ill advised.

Citing Articles

Biosafety, biosecurity, and bioethics.

Resnik D Monash Bioeth Rev. 2024; 42(1):137-167.

PMID: 39078602 PMC: 11368980. DOI: 10.1007/s40592-024-00204-3.


Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory.

Albarnaz J, Torres A, Smith G Viruses. 2018; 10(3).

PMID: 29495547 PMC: 5869494. DOI: 10.3390/v10030101.


Dynamics of Pathological and Virological Findings During Experimental Calpox Virus Infection of Common Marmosets (Callithrix jacchus).

Schmitt A, Gan L, Abd El Wahed A, Shi T, Ellerbrok H, Kaup F Viruses. 2017; 9(12).

PMID: 29182537 PMC: 5744138. DOI: 10.3390/v9120363.


TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections.

Shen L, Mao H, Wu Y, Tanaka Y, Zhang W Biochimie. 2017; 142:1-10.

PMID: 28778717 PMC: 7116903. DOI: 10.1016/j.biochi.2017.07.016.


Immunomodulator-based enhancement of anti smallpox immune responses.

Martinez O, Miranda E, Ramirez M, Santos S, Rivera C, Vazquez L PLoS One. 2015; 10(4):e0123113.

PMID: 25875833 PMC: 4395221. DOI: 10.1371/journal.pone.0123113.


References
1.
Alejo A, Ruiz-Arguello M, Ho Y, Smith V, Saraiva M, Alcami A . A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus. Proc Natl Acad Sci U S A. 2006; 103(15):5995-6000. PMC: 1458686. DOI: 10.1073/pnas.0510462103. View

2.
Rimoin A, Mulembakani P, Johnston S, Lloyd Smith J, Kisalu N, Kinkela T . Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci U S A. 2010; 107(37):16262-7. PMC: 2941342. DOI: 10.1073/pnas.1005769107. View

3.
Mohamed M, Rahman M, Lanchbury J, Shattuck D, Neff C, Dufford M . Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses. Proc Natl Acad Sci U S A. 2009; 106(22):9045-50. PMC: 2683884. DOI: 10.1073/pnas.0900452106. View

4.
Karem K, Reynolds M, Hughes C, Braden Z, Nigam P, Crotty S . Monkeypox-induced immunity and failure of childhood smallpox vaccination to provide complete protection. Clin Vaccine Immunol. 2007; 14(10):1318-27. PMC: 2168110. DOI: 10.1128/CVI.00148-07. View

5.
Brichacek B, Vanpouille C, Trachtenberg A, Pushkarsky T, Dubrovsky L, Martin G . Long-term changes of serum chemokine levels in vaccinated military personnel. BMC Immunol. 2006; 7:21. PMC: 1578581. DOI: 10.1186/1471-2172-7-21. View